Edwards Lifesciences (EW) SVP awarded RSUs, options and has shares withheld for taxes
Rhea-AI Filing Summary
Edwards Lifesciences Corp senior vice president and corporate controller Andrew M. Dahl reported routine equity compensation changes. On May 7, 2026, he acquired 7,005 shares of Common Stock through grants at no cost and received employee stock options on 6,745 shares with an exercise price of $82.76 per share.
The restricted stock units and options were granted under the company’s Long-Term Stock Incentive Compensation Program and are scheduled to vest and become exercisable in four equal annual installments starting one year after the grant date. On May 8, 2026, 289 shares of Common Stock were withheld at $82.76 per share to cover tax obligations, leaving Dahl with 15,901.6214 shares of Common Stock held directly after these transactions.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 6,716 shares
Net Buy
4 txns
Insider
Dahl Andrew M.
Role
SVP, Corporate Controller
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise Price or Tax Liability | Common Stock | 289 | $82.76 | $24K |
| Grant/Award | Employee Stock Option (Right to Acquire) | 6,745 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 3,985 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 3,020 | $0.00 | $0.00 |
Holdings After Transaction:
Employee Stock Option (Right to Acquire) — 6,745 shares (Direct);
Common Stock — 15,901.6214 shares (Direct)
Footnotes (2)
- F1. These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
- F2. These options were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested and exercisable commencing one year after the grant date in four equal annual installments.
Key Figures
RSU grants: 7,005 shares
Stock options granted: 6,745 options
Option exercise price: $82.76 per share
+5 more
8 metrics
RSU grants
7,005 shares
Restricted stock units granted on May 7, 2026
Stock options granted
6,745 options
Employee stock options granted May 7, 2026
Option exercise price
$82.76 per share
Exercise price for 6,745 stock options
Tax-withholding shares
289 shares
Shares withheld for tax obligations on May 8, 2026
Price for tax withholding
$82.76 per share
Value used for 289-share tax-withholding disposition
Post-transaction holdings
15,901.6214 shares
Common Stock directly held after transactions
Derivative transactions
1 transaction
Single derivative grant reported in Form 4
Tax-withholding count
1 transaction
One F-code tax-withholding disposition
Key Terms
restricted stock units, Employee Stock Option (Right to Acquire), Long-Term Stock Incentive Compensation Program, tax-withholding disposition, +1 more
5 terms
restricted stock units financial
"These restricted stock units were granted on May 7, 2026 under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
Employee Stock Option (Right to Acquire) financial
"security_title": "Employee Stock Option (Right to Acquire)""
Long-Term Stock Incentive Compensation Program financial
"under the Edwards Lifesciences Corporation Long-Term Stock Incentive Compensation Program and are scheduled to become vested"
tax-withholding disposition financial
"transaction_action": "tax-withholding disposition""
A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.
grant/award acquisition financial
"transaction_action": "grant/award acquisition""
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What insider transactions did Edwards Lifesciences (EW) report for Andrew M. Dahl?
Edwards Lifesciences reported that Andrew M. Dahl received equity awards and a small tax-related share withholding. He was granted restricted stock units, stock options, and had 289 shares withheld to satisfy tax liabilities, all as part of routine compensation arrangements.
What stock options did Andrew M. Dahl receive from Edwards Lifesciences (EW)?
Andrew M. Dahl received employee stock options covering 6,745 shares of Edwards Lifesciences Common Stock. The options have an exercise price of $82.76 per share and vest in four equal annual installments beginning one year after the May 7, 2026 grant date.
When do Andrew M. Dahl’s new Edwards Lifesciences (EW) equity awards vest?
Both the restricted stock units and stock options granted on May 7, 2026 are scheduled to vest and become exercisable in four equal annual installments. Vesting begins one year after the grant date, providing a multi-year incentive alignment with company performance.